Literature DB >> 30148899

[Results of a multicentric colorectal cancer screening program in Chile].

Francisco López-Kostner1, Alejandro J Zárate1, Alejandra Ponce1, Udo Kronberg1, Hiroshi Kawachi2, Takuya Okada2, Masahiro Tsubaki2, Takashi Ito2, Tetsuro Nishikage2, Koji Tanaka2, Tatsuyuki Kawano2, Yoshinobu Eishi2, Paulina Peñaloza3, Ricardo Estela4, Stanko Karelovic5, Sergio Flores6.   

Abstract

BACKGROUND: Colorectal Cancer Screening Programs (CRCSP) are widely accepted in developed countries. Unfortunately, financial restrictions, low adherence rate and variability on colonoscopy standardization hamper the implementation of CRCSP in developing countries. AIM: To analyze a multicentric pilot model of CRCSP in Chile.
MATERIAL AND METHODS: A prospective model of CRCSP was carried out in three cities, from 2012 to 2015. The model was based on CRC risk assessment and patient education. Health care personnel were trained about logistics and protocols. The endoscopy team was trained about colonoscopy standards. A registered nurse was the coordinator in each center. We screened asymptomatic population aged between 50 and 75 years. Immunological fecal occult blood test (FIT) was offered to all participants. Subjects with positive FIT underwent colonoscopy.
RESULTS: A total of 12,668 individuals were enrolled, with a FIT compliance rate of 93.9% and 2,358 colonoscopies were performed. Two hundred and fifty high-risk adenomas and 110 cancer cases were diagnosed. One patient died before treatment due to cardiovascular disease, 74 patients (67%) underwent endoscopic resection and 35 had surgical treatment. Ninety one percent of patients had an early stage CRC (0-I-II). Among colonoscopy indicators, 80% of cases had an adequate bowel preparation (Boston > 6), cecal intubation rate was 97.7%, adenoma detection rate was 36.5%, and in 94.5% of colonoscopies, withdrawal time was adequate (> 8 min).
CONCLUSIONS: This CRCS pilot model was associated to a high rate of FIT return and colonoscopy quality standards. Most CRCs detected with the program were treated by endoscopic resection.

Entities:  

Mesh:

Year:  2018        PMID: 30148899     DOI: 10.4067/s0034-98872018000600685

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  2 in total

1.  Is Colorectal Cancer Screening Appropriate in Nigeria?

Authors:  Gregory C Knapp; Olusegun I Alatise; Olalekan O Olasehinde; Ademola Adeyeye; Omobolaji O Ayandipo; Martin R Weiser; T Peter Kingham
Journal:  J Glob Oncol       Date:  2019-06

2.  [Cancer care access in Chile's vulnerable populations during the COVID-19 pandemicAcesso a tratamento de câncer em populações vulneráveis no Chile durante a pandemia de COVID-19].

Authors:  Cristóbal Cuadrado; Francisca Vidal; Jorge Pacheco; Sandra Flores-Alvarado
Journal:  Rev Panam Salud Publica       Date:  2022-08-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.